Delivery Order SPE2DB22D2007-SPE2DB25FJ0QV

Award Date 4/14/25
Potential Completion Date 5/5/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product, with a ceiling value of $22,175.20. The contract is a firm fixed-price delivery order with a period of performance through May 22, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of PADCEV 30 MG VIALS. The contract has a ceiling value of $8,315.70 and a period of performance through January 30, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,087.60, is for the supply of PADCEV 30 MG VIALS medical products. It is a firm fixed-price contract with a completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG vials. The contract has a ceiling value of $7,499.79 and runs through November 4, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. As a key supplier of pharmaceutical and medical products to the federal government, including military treatment facilities and veterans' healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PADCEV 30 MG VIALS, a specialty pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $15,517.98, and a period of performance through December 13, 2024. This contract is a child award under a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 30 MG vials, a prescription medication, with a ceiling value of $11,087.60 and a period of performance through June 2, 2025. The contract is not set aside and is a firm fixed price, delivery order contract type. AmerisourceBergen Drug Corp holds a larger Indefinite...
This federal contract award, valued at $22,175.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product, with a completion date of February 25, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a Set-Aside contract. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $9,999.72, is for the delivery of the pharmaceutical product PADCEV 30 MG VIALS. The contract has a firm fixed price pricing type and a completion date of May 21, 2024. This order is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,695.90 firm-fixed-price contract is for the delivery of PADCEV 20 MG VIAL 1S, a pharmaceutical product, with a period of performance through June 9, 2025. The contract is not set aside for any small business or socioeconomic program. AmerisourceBergen Drug Corp also holds a much larger...
This federal contract award, valued at $18,479.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 20 MG VIALS, a pharmaceutical product, with a completion date of March 25, 2025. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ0QV
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PADCEV 30 MG VIALS, with a ceiling value of $11,087.60 and a completion date of May 5, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/14/25, 10:44 AM